CCA
Conestoga Capital Advisors Portfolio holdings
AUM
$6.77B
This Quarter Return
+0.14%
1 Year Return
+15.03%
3 Year Return
+67.7%
5 Year Return
+109.33%
10 Year Return
+516.93%
AUM
$1.49B
AUM Growth
+$1.49B
(-5.7%)
Cap. Flow
-$50.5M
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
29.45%
Holding
140
New
5
Increased
33
Reduced
71
Closed
10
Top Buys
| 1 |
Repligen
RGEN
|
$23.8M |
| 2 |
CMD
Cantel Medical Corporation
CMD
|
$16.3M |
| 3 |
Ligand Pharmaceuticals
LGND
|
$15.2M |
| 4 |
Mesa Laboratories
MLAB
|
$4.83M |
| 5 |
Dorman Products
DORM
|
$2.71M |
Top Sells
| 1 |
HITT
HITTITE MICROWAVE CORP
HITT
|
$26.4M |
| 2 |
ABAX
Abaxis Inc
ABAX
|
$15.2M |
| 3 |
FARO
Faro Technologies
FARO
|
$14.7M |
| 4 |
BCPC
Balchem Corporation
BCPC
|
$6.66M |
| 5 |
CRR
Carbo Ceramics Inc.
CRR
|
$4.65M |
Sector Composition
| 1 | Technology | 23.65% |
| 2 | Healthcare | 20.07% |
| 3 | Industrials | 15.68% |
| 4 | Materials | 8.38% |
| 5 | Consumer Discretionary | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Grand Canyon Education
LOPE
$5.77B
| $30.6M | 2.05% |
665,201
-44,424
| -6% | -$2.04M |
|
|
FLTX
27
DELISTED
Fleetmatics Group PLC
FLTX
| $30.5M | 2.05% |
943,181
+46,631
| +5% | +$1.51M |
|
|
MCF
28
DELISTED
Contango Oil & Gas Co.
MCF
| $29M | 1.94% |
684,922
+20,192
| +3% | +$854K |
|
|
ABAX
29
DELISTED
Abaxis Inc
ABAX
| $28.4M | 1.91% |
641,146
-342,414
| -35% | -$15.2M |
|
30
Stratasys
SSYS
$863M
| $27.2M | 1.83% |
239,796
-10,215
| -4% | -$1.16M |
|
|
HIBB
31
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $26.9M | 1.81% |
497,170
-32,026
| -6% | -$1.73M |
|
|
EGOV
32
DELISTED
NIC Inc
EGOV
| $26.6M | 1.79% |
1,680,458
-10,945
| -0.6% | -$173K |
|
|
33
Mesa Laboratories
MLAB
$338M
| $26.2M | 1.76% |
311,881
+57,570
| +23% | +$4.83M |
|
|
FARO
34
DELISTED
Faro Technologies
FARO
| $25.7M | 1.72% |
522,438
-299,423
| -36% | -$14.7M |
|
|
SQI
35
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $25M | 1.68% |
1,412,432
-32,564
| -2% | -$576K |
|
|
ABCO
36
DELISTED
Advisory Board Co/The
ABCO
| $24M | 1.61% |
463,795
-46,715
| -9% | -$2.42M |
|
|
37
Repligen
RGEN
$6.54B
| $23.8M | 1.6% |
+1,044,319
| New | +$23.8M |
|
38
Rollins
ROL
$27.3B
| $22.7M | 1.53% |
758,296
-124,493
| -14% | -$3.73M |
|
|
MDSO
39
DELISTED
Medidata Solutions, Inc.
MDSO
| $21.1M | 1.41% |
492,550
+15,533
| +3% | +$665K |
|
40
Bio-Techne
TECH
$8.3B
| $15.9M | 1.07% |
172,057
-2,922
| -2% | -$270K |
|
41
NVE Corp
NVEC
$307M
| $15.5M | 1.04% |
278,373
+7,741
| +3% | +$430K |
|
42
Medifast
MED
$153M
| $15.4M | 1.03% |
506,793
+28,730
| +6% | +$874K |
|
|
VIVO
43
DELISTED
Meridian Bioscience Inc
VIVO
| $15.2M | 1.02% |
737,319
+6,722
| +0.9% | +$139K |
|
|
44
Ligand Pharmaceuticals
LGND
$3.25B
| $15.2M | 1.02% |
+243,967
| New | +$15.2M |
|
|
NRCIB
45
DELISTED
National Research Corp Class B
NRCIB
| $14.7M | 0.99% |
376,236
+48,058
| +15% | +$1.88M |
|
46
Morningstar
MORN
$10.8B
| $13.9M | 0.93% |
194,012
-38,704
| -17% | -$2.78M |
|
47
Acacia Research
ACTG
$312M
| $13.6M | 0.91% |
767,401
+11,669
| +2% | +$207K |
|
48
National Research Corp
NRC
$340M
| $13.4M | 0.9% |
954,225
-17,193
| -2% | -$241K |
|
|
EXA
49
DELISTED
EXA Corporation
EXA
| $7.1M | 0.48% |
630,077
+44,577
| +8% | +$502K |
|
50
UNIFI
UFI
$80.2M
| $4.18M | 0.28% |
151,804
+1,025
| +0.7% | +$28.2K |
|